NCT01853280View on ClinicalTrials.gov

L-methylfolate Supplementation to OROS-Methylphenidate Pharmacotherapy in ADHD Adults

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

February 28, 2017

Study Completion Date

September 30, 2017

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

L-methylfolate

15mg/day L-methylfolate.

DRUG

OROS-Methylphenidate

All subjects will be treated with open-label OROS-MPH

DRUG

Placebo

15 mg matched placebo comparator, with open-label OROS-Methylphenidate

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Pamlab, Inc.

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT01853280 - L-methylfolate Supplementation to OROS-Methylphenidate Pharmacotherapy in ADHD Adults | Biotech Hunter | Biotech Hunter